Serum metabolome aging signature
1 paper2 findings
- Human trial1
Interventions
1Losartan
downin humans1downin mice1
1 study
Losartan
downin humans1downin mice1
Losartan decreases serum metabolome aging signature in humans.
“a phase 2 randomized placebo-controlled trial of losartan, which indicated a dose-dependent metabolic rejuvenation effect.”
Human trialpre-frail; phase 2 randomized placebo-controlled trialserummales
Aging cell22 Apr 2026
Losartan decreases serum metabolome aging signature in mice.
“Losartan treatment resulted in a shift in serum metabolome aging signature to a more youthful state.”
Animalsserummales
Aging cell22 Apr 2026